Pharmacological properties of indazole derivatives: Recent developments

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 10, 2005, Pages 869-878

  Cerecetto, Hugo ^a   Gerpe, Alejandra ^a   González, Mercedes ^a   Arán, Vicente J ^b   Ochoa de Ocáriz, Carmen ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (3 DIMETHYLAMINOPROPOXY)INDAZOLE; 1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 7 METHOXYINDAZOLE; 7 NITROINDAZOLE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZENE DERIVATIVE; CONTRACEPTIVE AGENT; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; GYRASE INHIBITOR; IMIDAZOLE DERIVATIVE; INDAZOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; RHO KINASE; RHO KINASE INHIBITOR; SEROTONIN 1 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TRIAZENE DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ASTHMA; BINDING AFFINITY; CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTRACEPTION; CROHN DISEASE; DEGENERATIVE DISEASE; DERMATITIS; DIABETIC RETINOPATHY; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; EATING DISORDER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HELA CELL; HUMAN; HYPERTENSION; IC 50; INFLAMMATORY DISEASE; MIGRAINE; NEOVASCULAR GLAUCOMA; NEUROPROTECTION; NONHUMAN; OBESITY; OSTEOPOROSIS; PAIN; PARKINSON DISEASE; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; STROKE; STRUCTURE ACTIVITY RELATION; VASCULAR DISEASE; VEIN INSUFFICIENCY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CONTRACEPTIVE AGENTS, MALE; CYCLIC N-OXIDES; HUMANS; INDAZOLES; OSTEOPOROSIS; PARASITIC DISEASES; VASODILATOR AGENTS;

EID: 24944564781     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955705774329564     Document Type: Review

References (90)

1. a) Speranza, M. Adv. Heterocycl. Chem., 1985, 40, 25.
2. b) Catalan, J., de Paz, J.L.G., Elguero, J. J. Chem. Soc. Perkin Trans., 1985, 2, 57.
3. a) Latosinska, J.N.; Kasprzak, J.; Kazimierczuk, Z. J. Mol. Struct. (Theochem), 2000, 530, 217.
4. b) Pergolese, B.; Bigotto, A. Spectrochimica Acta Part A. 2001, 57, 1191.
5. c) Ögretir, C., Funda Kaypak, N. J. Mol. Struct. (Theochem), 2002, 583, 137.
6. d) Ögretir, C., Funda Kaypak, N. J. Mol. Struct. (Theochem), 2002, 588, 145.
7. a) Caron, S., Eisenbeis, S. A. U. S. P. 6011159, Jan. 4, 2000.
8. b) Marfat, A. U. S. P. 6040329, Mar. 21, 2000.
9. c) Marfat, A. U S. P. 6211222, Apr. 3, 2001.
10. d) Lien, J.C., Lee, F. Y., Huang, T. M., Huang, L. J., Teng, C. M., Tsai, S. C., Wu, C. C., Cheng, F. C., Kuo, S. C. J. Med. Chem., 2001, 44, 3746.
11. e) Lien, J.C., Lee, F. Y., Huang, L. J., Pan, S. L., Guh, J. H., Teng, C. M., Kuo, S. C. J. Med. Chem., 2002, 45, 4947.
12. Selwood, D.J.; Brummell, D.G.; Budworth, J.; Burtin, G.E.; Campbell, R.O.; Chana, S.S.; Charles, I.G.; Fernandez, P.A.; Glen, R.C.; Goggin, M.C.; Hobbs, A.J.; Kling, M.R.; Liu, Q.; Madge, D.J.; Meillerais, S.; Powell, K.L.; Reynolds, K.; Spacey, G.D.; Stables, J.N.; Tatlock, M.A.; Wheeler, K.A.; Wishart, G.; Woo, C.K. J. Med. Chem. 2001, 44, 78.
13. a) Arán V.J., Stud M., J. Heterocyclic Chem., 1985, 22, 1743.
14. b) Arán V.J., Stud M., Tetrahedron Lett., 1988, 697.
15. c) Arán V.J., Asencio J.L., Ruiz J.R., Stud M., J. Chem. Res., 1993, 1319.
16. d) Arán V.J., Asencio J.L., Ruiz J.R., Stud M., J. Chem. Soc. Perkin I, 1993, 1119.
17. e) Arán V.J., Flores M., Muñoz P., Péaz J.A., Sánchez-Verdú P., Stud M., Liebigs Ann., 1995, 817.
18. f) Arán V.J., Flores M., Muñoz P., Péaz J.A., Sánchez-Verdú P., Stud M., Liebigs Ann., 1996, 683.
19. Batt, D. G., Petraitis, J. J., Houghton, G. C., Modi, D. P., Cain, G. A., Corjay, M. H., Mousa, S. A., Bouchard, P. J., Forsythe, M. S., Harlow, P. P., Barbera, F. A., Spitz, S. M., Wexler, R. R., Jadhav, P. K. J. Med. Chem., 2000, 43, 41.
20. a) Saczewski, F., Saczewski, J., Gdanies, M., Chem. Pharm. Bull., 2001, 49, 1203.
21. b) Saczewski, F., Saczewski, J., Hudson, A. L., Tyacke, R. J., Nutt, D. J., Man, J., Tabin, P. Eur. J. Pharmaceutical Sci., 2003, 20, 201.
22. a) Zenchoff, G.S.; Walser, A.; Fryer, R.I. J. Het. Chem., 1976, 13, 33.
23. b) Molina, P.; Soler, A.; Vilaplana, M.J. Anales de Química, 1979, 75, 739.
24. a) Heller, G.; Spielmeyer, G. Chem. Ber., 1925, 58, 834.
25. b) Reissert, A.; Lemmer, F. Chem. Ber., 1926, 59, 351.
26. c) Secareanu, S.; Lupas, I.; Bull. Soc. Chim. Fr., 1933, 53, 1436.
27. d) Secareanu, S.; Lupas, I. Bull. Soc. Chim. Fr., 1934, 53(4), 373.
28. e) Secareanu, S.; Lupas, I. Bull. Soc. Chim. Fr., 1935, 5 (2), 69.
29. f) Tanasescu, I.; Tanasescu, E. Bull. Soc. Chim. Fr., 1935, 5 (2), 1016.
30. g) Akashi, K. Bull. Inst. Phys. Chem. Research, 1941, 20, 798. CA. 1949, 7934.
31. h) Behr, L.C. J. Amer. Chem. Soc. 1954, 76, 3672.
32. i) Behr, L.C.; Alley, E.G.; Levand, O. J. Org. Chem., 1962, 27, 65.
33. j) Johnston, D.; Smith, D.M. Tetrahedron Lett., 1975, 1121.
34. k) Johnston, D.; Smith, D.M. J. Chem. Soc. Perkin Trans I, 1987, 495.
35. Nyerges, M.; Fejes, I. Tetrahedron Lett., 2001, 42, 5081.
36. a) Kametani, T.; Sota, K.; Shio, M. J. Het. Chem., 1970, 4, 875.
37. b) Boulton, A.J.; Kan-Woo, T. J. Chem. Soc. Chem. Comm., 1978, 1052.
38. a) Boulton, A.J.; Kan-Woon, T. J. Org. Chem., 1980, 45, 1653.
39. b) Boulton, A.J. Bull. Soc. Chem. Belg., 1981, 90, 645.
40. a) Bamberg, E. Chem. Ber., 1922, 55, 3371.
41. b) Takada, K.; Kan-Woon, T.; Boulton, A.J. J. Org. Chem., 1982, 47, 4323.
42. Zenchoff, G.S.; Walser, A.; Fryer, R.I. J. Het. Chem., 1976, 13, 33.
43. a) Stamler, J.S.; Singel, D.J.; Loscalzo, J. Science, 1992, 258, 1898.
44. b) Gasco, A.; Fruttero, R.; Sorba, G. Farmaco, 1996, 51, 617, and references therein.
45. c) Schönafinger, K. Farmaco, 1999, 54, 316.
46. d) Davis, K.L.; Martin, E.; Turko, I.V.; Murad, F. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 203, and references therein.
47. Alderton, W.K.; Cooper, C.E.; Knowies, R.G. Biochem. J. 2001, 357, 593.
48. Moore, P.K..; Wallace, P.; Gaffen, Z.; Hart, S.L.; Babbedge, R.C. Br. J. Pharmacol. 1993, 110, 219.
49. Moore, P.K.; Hart, S.L.; Babbedge, R.C.; Bland-Ward, P.A. Br. J. Pharmacol. 1993, 110, 225.
50. a) Wolff, D.J.; Gribin, B.J. Arch. Biochem. Biophys. 1994, 311, 300.
51. b) Wolff, D.J.; Lubeskie, A.; Umansky, S. Arch. Biochem. Biophys. 1994, 314, 360.
52. c) Mayer, B.; Klatt, P.; Werner, E.R.; Schmidt, K. Neuropharmacology, 1994, 33, 1253.
53. d) Moore, R.C.; Bland-Ward, P.A. Life Sci, 1995, 57, PL131.
54. e) Zhang, Y., Dawson, V. L., Dawson, T. M. Neurobiol. Dis., 2000, 7, 240.
55. f) Tayfun, U.; Harbans, L. Prog. Neuro-Psychopharmacol. Biol. Psych., 2002, 26, 567.
56. a) Schumann, P.; Collot, V.; Hommet, Y.; Gsell, W.; Dauphin, F.; Sopkova, J.; MacKenzie, E.T.; Duval, D.; Boulouard, M.; Rault, S. Bioorg. Med. Chem. Lett. 2001, 11, 1153.
57. b) Raman, C. S.; Li, H.; Martasek, P.; Southan, G.; Masters, B. S. S.; Poulos, T. L. Biochem, 2001, 40, 13448.
58. c) Tuynman, A.; Pérollier, C.; Frapart, Y.; Schumann-Bard, P.; Collot, V.; Rault, S.; Boucher, J.L. Nitric Oxide, 2003, 9, 86.
59. a) Tulis, D. A.; Durante, W.; Peyton, K. J.; Chapman, G. B.; Evans, A. J.; Schafer, A. I. Biochem. Biophys. Res. Comm. 2000, 279, 646.
60. b) Wu, S. N.; Hwang, T. L.; Teng, C. M.; Li, H. F.; Jan, C. R. Neuropharmacology, 2000, 39, 1788.
61. c) Wu, C. H.; Chang, W. C.; Chang, G. Y.; Kuo, S. C.; Teng, C. M. J. Pharmacol. Sci. 2004, 94, 252.
62. Marfat, A. U. S. P. 6716978, Apr. 6, 2004.
63. Schindler, R.; Fleischhauer, I.; Hofgen, N.; Sauer, W.; Egerland, U.; Poppe, H.; Heer, S.; Szelenyi, I.; Kutscher, B.; Engel, J. Arch. Pharm. Pharm. Med. Chem. 1998, 331, 13.
64. Lavielle, G.; Muller, O.; Vayssettes-Courchay, C.; Descombes, J.J.; Verbeuren, T. U. S. P. 6046205, Apr. 4, 2000.
65. a) Andreonati, S.; Sava, V.; Makan, S.; Kolodeev, G. Pharmazie, 1999, 54, 99.
66. b) Paluchowska, M.H.; Duszynska, B.; Klodzinska, A.; Tatarzynska, E. Pol. J. Pharmacol. 2000, 52, 209.
67. Suzuki, M.; Ureno, M.; Fukutomi, R.; Satoh, H.; Kikuchi, H.; Hagihara, K.; Arai, T.; Taniguchi, S.; Mino, S.; Noguchi, Y. U.S.P. 6096746, Aug. 1, 2000.
68. Alisi, A.; Brufoni, M.; Cazzolla, N.; Giannangeli, M.; Pinza, M. U. S. P. 6197769, Mar, 6, 2001.
69. Keppler, B. K.; Henn, M.; Juhl, U. M.; Berger, M. R.; Niebl, R.; Wagner, F. F. Prog. Clin. Biochem. Med. 1989, 10, 41.
70. Pruss, G. J.; Drlica, K. Proc. Natl. Acad. Sci. USA, 1986, 83, 8952.
71. Gopal, Y.N.V.; Kondapi, A.K. J. Biosci. 2001, 26, 271.
72. a) Kania, R.S.; Bender, S.L.; Borchardt, A.J.; Cripps, S.J.; Hua, Y.; Johnson, M.D.; Johnson, T. O.; Luu, H. T.; Palmer, C. L.; Reich, S.H.; Tempczyk-Russell, A.M.; Teng, M.; Thomas, C.; Varney, M. D.; wallace, M. B.; Collins, M.R. U. S. P. 6534524, Mar. 18, 2003.
73. b) Reich, S.H.; Blekman, T.M.; Kephart, S. E.; Romines, W. H.; Wallace, M.B. U. S. P. 6555539, Apr. 29, 2003.
74. a) Diana, P.; Barraja, P.; Lauria, A.; Almerico, A.M.; Cirrincione, G.; Loi, A.; Musiu, C.; Pani, A.; La Colla, P.; Marongiu, M. Eur. J. Med. Chem. 1999, 34, 353.
75. b) Diana, P.; Barraja, P.; Lauria, A.; Almerico, A.M.; Cirrincione, Minnie, C.; Longu, C.; Congiu, D.; Musiu, C.; La Colla, P.; Anticancer Res. 1999, 19, 2127.
76. c) Daidone, G.; Raffa, D.; Maggio, B.; Raimondi, M.F.; Plescia, F.; Schillaci, D. Eur. J. Med. Chem. 2004, 39, 219.
77. Boehringer, M.; Boehm, H.J.; Bur, D.; Gmuender, H.; Huber W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. J. Med. Chem. 2000, 43, 2664.
78. Tanitame, A.; Oyamada, Y.; Ofuji, K.; Kyoya, Y.; Suzuki, K.; Ito, H.; Kawasaki, M.; Nagai, K.; Wachi, M.; Yamagishi, J. Bioorg. Med. Chem. Lett. 2004, 14, 2857.
79. Li, X.; Chu, S.; Feher, V.A.; Khalili, M.; Nie, Z.; Margosiak, S.; Nikulin, V.; Levin, J.; Sprankle, K.G.; Tedder, M.E.; Almassy, R.; Appelt, K.; Yager, K.M. J. Med. Chem. 2003, 46, 5663.
80. Arán, V.J.; Ochoa, C.; Boiani, L.; Buccino, P.; Cerecetto, H.; Gerpe, A.; González, M.; Montero, D.; Nogal, J.J.; Gómez-Barrio, A.; Azqueta, A.; López de Ceráin, A.; Piro, O.E.; Castellano, E.E. Bioorg. Med. Chem. 2005, 13, 3197.
81. Boiani, L.; Cerecetto, H.; Gerpe, A.; González, M.; Ochoa, C.; Montero, D.; Nogal, J.J.; Gómez-Barrio, A. Unpublished data.
82. Takami, A.; Iwakubo, M.; Okada, Y.; kawata, T.; Odai, H.; Takahashi, N.; Sindo, K.; Kimura, K.; Tagami, Y.; Miyake, M.; Fukushima, K.; Inagaki, M.; Amano, M.; Kaibuchi, K.; Iijima, H. Bioorg. Med. Chem. 2004, 12, 2115.
83. a) Silvestrini, B.; Cheng, C.Y. U.S.P. 6001865, 1999.
84. b) Gong, X.D.; Wong, Y.L; Leung, G.P.H.; Cheng, C.Y.; Silvestrini, B.; Wong, P.Y.D. Biol Reprod, 2000, 63, 833.
85. c) Grima, J.; Silvestrini, B.; Cheng, C.Y. Biol Reprod, 2001, 64, 1500.
86. d) Cheng, C.Y.; Silvestrini, B.; Grima, J. Biol Reprod 2001, 65, 49.
87. e) Cheng, C.Y.; Mo, M.; Grima, J.; Saso, L.; Tita, B.; Mruk, D.; Silvestrini, B. Contraception, 2002, 65, 265.
88. Ricotti, L.; Tesei, A.; De Paola, F.; Milandri, C.; Amadori, D.; Frassineti, G.L.; Ulivi, P.; Solí, W. J. Chemother. 2003, 15, 480.
89. a) Gong, X.D.; Linsdell, P.; Cheung, K.H.; Leung, G.P.H.; Wong, P.Y.D. Biol Reprod 2002, 67, 1888.
90. b) Siu, M.K.; Cheng C.Y. Biol Reprod, 2004, 70, 945.